Melief CJ - Search Results

1

CD4 T cells and their role in antitumor immune responses.

Toes RE, Ossendorp F, Offringa R, Melief CJ. Toes RE, et al. Among authors: melief cj. J Exp Med. 1999 Mar 1;189(5):753-6. doi: 10.1084/jem.189.5.753. J Exp Med. 1999. PMID: 10049938 Free PMC article. No abstract available.

2

CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.

den Boer AT, van Mierlo GJ, Fransen MF, Melief CJ, Offringa R, Toes RE. den Boer AT, et al. Among authors: melief cj. Cancer Res. 2005 Aug 1;65(15):6984-9. doi: 10.1158/0008-5472.CAN-04-3344. Cancer Res. 2005. PMID: 16061684

3

Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.

van Hall T, Sijts A, Camps M, Offringa R, Melief C, Kloetzel PM, Ossendorp F. van Hall T, et al. J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483. J Exp Med. 2000. PMID: 10952718 Free PMC article.

4

Activation or frustration of anti-tumor responses by T-cell-based immune modulation.

Toes RE, Schoenberger SP, van der Voort EI, Kast WM, Hoeben RC, Melief CJ, Offringa R. Toes RE, et al. Among authors: melief cj. Semin Immunol. 1997 Oct;9(5):323-7. doi: 10.1006/smim.1997.0088. Semin Immunol. 1997. PMID: 9327527 Review.

5

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.

Ossendorp F, Mengedé E, Camps M, Filius R, Melief CJ. Ossendorp F, et al. Among authors: melief cj. J Exp Med. 1998 Mar 2;187(5):693-702. doi: 10.1084/jem.187.5.693. J Exp Med. 1998. PMID: 9480979 Free PMC article.

6

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.

Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, Offringa R, Toes RE. Diehl L, et al. Among authors: melief cj. Nat Med. 1999 Jul;5(7):774-9. doi: 10.1038/10495. Nat Med. 1999. PMID: 10395322

7

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein.

Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R. Medema JP, et al. Among authors: melief cj. J Exp Med. 1999 Oct 4;190(7):1033-8. doi: 10.1084/jem.190.7.1033. J Exp Med. 1999. PMID: 10510093 Free PMC article.

8

Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.

Schuurhuis DH, Laban S, Toes RE, Ricciardi-Castagnoli P, Kleijmeer MJ, van der Voort EI, Rea D, Offringa R, Geuze HJ, Melief CJ, Ossendorp F. Schuurhuis DH, et al. Among authors: melief cj. J Exp Med. 2000 Jul 3;192(1):145-50. doi: 10.1084/jem.192.1.145. J Exp Med. 2000. PMID: 10880536 Free PMC article.

9

Importance of CD4(+) T helper cell responses in tumor immunity.

Ossendorp F, Toes RE, Offringa R, van der Burg SH, Melief CJ. Ossendorp F, et al. Among authors: melief cj. Immunol Lett. 2000 Sep 15;74(1):75-9. doi: 10.1016/s0165-2478(00)00252-2. Immunol Lett. 2000. PMID: 10996631 Review. No abstract available.

10

The role of CD40 in peripheral T cell tolerance and immunity.

Diehl L, Den Boer AT, van der Voort EI, Melief CJ, Offringa R, Toes RE. Diehl L, et al. Among authors: melief cj. J Mol Med (Berl). 2000;78(7):363-71. doi: 10.1007/s001090000126. J Mol Med (Berl). 2000. PMID: 11043379 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

543 results

Search Page